Self-monitoring of blood glucose is used to assist patients with diabetes in achieving and maintaining blood glucose concentrations close to those found in individuals without diabetes. This goal requires that blood glucose monitors meet analytical performance criteria that are appropriate for patient care (1-3 ). The lack of accuracy of monitors and the resulting variability among monitors limit their use for assessing and maintaining glycemic control (4, 5 ) .
Self-monitoring of blood glucose is used to assist patients with diabetes in achieving and maintaining blood glucose concentrations close to those found in individuals without diabetes. This goal requires that blood glucose monitors meet analytical performance criteria that are appropriate for patient care (1) (2) (3) . The lack of accuracy of monitors and the resulting variability among monitors limit their use for assessing and maintaining glycemic control (4, 5 ) .
No suitable means exists for establishing calibration traceability between a glucose monitor and a reference method. In the absence of a whole-blood glucose reference material, the recommended approach to establishing traceability is to perform split-sample comparisons with patient samples and a reference method (6 ) . This can be achieved by following the Clinical and Laboratory Standards Institute (NCCLS) EP9-A2 (7 ) guideline procedure. Because the capillary whole blood required by these monitors usually is available only in small amounts and because glucose is not stable in this matrix, such splitsample comparison studies are difficult to perform, particularly when specimens need to be transported elsewhere (8 ) . Capillary collection devices have been used in method-comparison studies to characterize glucose monitors (8 -13 ) , but data on the stability and reproducibility of glucose measurements of blood in these capillary collection devices are limited (8, 9 ) . In this study, we assessed a capillary collection procedure in combination with a gas chromatography-mass spectrometry (GC/MS) reference method for measuring glucose in whole blood.
The specimen collection procedure and measurement of glucose by GC/MS were based on a previously published method (9 ) . The specimen collection procedure consisted of filling a 1-L heparinized glass capillary with specimen and transferring it into a microcentrifuge tube containing 500 L of internal standard solution, which is an aqueous solution of [ 13 C 6 ]glucose (Cambridge Isotope Laboratories) at a concentration of 15 mmol/L (270 mg/dL). The tube was closed and shaken vigorously to remove the specimen from the capillary. The measurement of glucose was then performed (9 ) with protein precipitation, derivatization of glucose, and analysis of the glucose derivatives by GC/MS.
Calibration was performed with Standard Reference Material 917b [d-Glucose (Dextrose)] from NIST. The within-and among-day variabilities of this method were assessed with use of frozen serum pools (NIST SRM 965) and EDTA-whole blood that was aliquoted immediately after collection and frozen at Ϫ70°C until analysis. The frozen specimens were processed immediately as described above after thawing and homogenizing.
The method was linear within the tested glucose concentration range from 2 to 30 mmol/L (36 to 540 mg/dL) glucose and had a detection limit of 0.1 mmol/L (1.8 mg/dL) glucose. The mean recovery determined by addition of calibrators to SRM 965 was 100.3%. The differences between the measured and assigned values for the three "levels" of the NIST SRM 965 were 0.35%, 0.27%, and 0.85% at 5.68 mmol/L (100 mg/dL), 11.10 mmol/L (200 mg/dL), and 16.36 mmol/L (300 mg/dL), respectively. The within-day imprecision (CV) was 0.52% for EDTA-whole blood and 0.41%, 0.57%, and 0.40% for NIST SRM 965 at the three concentrations listed above (five replicates per concentration), respectively. The amongday imprecision (over 20 days) was 0.88% for whole blood and 1.6%, 1.2%, and 0.93%, respectively, for the three levels of NIST SRM 965.
To assess the stability of glucose, we stored a 1-L freshly collected venous EDTA-whole blood specimen under three different conditions: in a glass capillary, after transfer of the specimen from the glass capillary into water (500 L), and after transfer of the specimen from the glass capillary into internal standard solution (500 L). The durations tested were 0, 0.5, 1, 2, 6, and 8 h at 20°C for each condition. At the end of the storage time, the samples were processed as described above. The glucose concentrations in EDTA-whole blood stored at room temperature decreased faster (50% within 8 h and 90% after 24 h; Fig. 1 ) than in EDTA-whole blood diluted in water (15% and 20% after 8 and 24 h, respectively). The reasons for this improved stability are not fully understood. Diluting the sample with water lyses cells and changes the immediate environment of glycolytic en- zymes, including the pH and ionic strength. This may decrease enzyme activity and slow glucose degradation to a degree that differences between the aqueous solution and internal standard solution become apparent only after 8 h. The use of internal standard corrects for any loss of glucose during storage of diluted EDTA-whole blood. We concluded that diluting whole blood in aqueous internal standard solution enables the storage of this specimen for later blood glucose measurements. This finding was further assessed in a second experiment in which the stability of capillary whole-blood glucose after transfer into the internal standard solution was assessed at 20, 4, and Ϫ20°C. Three sets of samples (one set per storage temperature, each set with six capillaries collected from the same finger puncture) were prepared by collecting 1 L of capillary whole blood from one finger puncture, transferring the specimen from the glass capillary into the internal standard solution (500 L), and storing the resulting samples for 0, 0.25, 0.5, 1, 2, 3, 6, 12, 24, and 48 h at the described temperature. At the end of the storage time, the samples were processed as described above.
The glucose concentrations obtained at different time points were compared with those in samples processed immediately (time 0), and the percentage of glucose remaining was calculated (Table 1) . To assess the possible loss of glucose over time, we performed a polynomial regression using all data points obtained at each temperature. ANOVA was used to test whether a time point would be predictive for a certain loss. The obtained P values were 0.084, 0.926, and 0.134 for 20, 4, and Ϫ20°C, respectively. We conclude that no statistically significant loss over time was detected at any of the tested storage temperatures. The CVs for data from all time points (0 h to 48 h; n ϭ 60) were 2.0%, 2.3%, and 1.9% for 20, 4, and Ϫ20°C, respectively.
To establish traceability of results of glucose monitors and to assess accuracy in routine clinical settings, reference methods are needed that are characterized with whole blood, e.g., the method of Hannestad and Lundblad (9 ) . We adopted and modified this method by using smaller volume glass capillaries, which allow the collection of replicate samples from one finger puncture, as required by the NCCLS EP9-A2 procedure. The capillary collection procedures (9 ) require 50 L of specimen per measurement. Such a volume is difficult to obtain in replicate because of clotting during blood collection and the limited amount of available specimen from one finger puncture. Using 1-L glass capillaries, we were able to collect six capillaries in Ͻ1 min without observing problems with clotting or insufficient amounts of specimen. Furthermore, whereas larger volume capillaries require manual rinsing of the capillary to transfer the blood sample into the internal standard solution, small-volume capillaries fit into a microcentrifuge vial, allowing transfer of the sample by simply shaking the tube.
The observed rapid and profound glycolysis in whole blood is similar to previous study findings ( 14 -17 ) . However, as shown in this study, diluting the specimen with an aqueous solution of stable-isotope-labeled internal standard overcomes measurement problems associated with analyte loss even when the sample solution is stored over a period of 48 h. This allows samples to be collected and transported for measurement at a different site.
The described specimen collection procedure, including the use of stable-isotope-labeled internal standards, in combination with the GC/MS method provides a means to establish traceability in glucose monitors using patient samples, as recommended by ISO 17511, and offers a mechanism for calibration verification for manufacturers and external quality assessment programs. The GC/MS method allows the measurement of glucose in 1 L of capillary whole blood, EDTA-whole blood, or serum, with use of primary calibrators and secondary reference materials.
We thank Dr. Ulf Hannestad, University Hospital, Linkö-ping, Sweden, for help and assistance in setting up the GC/MS method. Cystatin C offers a promising alternative to serum creatinine as a marker of glomerular filtration (1, 2 ) . In children, cystatin C is particularly useful because its concentration is constant after the age of 1 year (3 ). Unlike creatinine, cystatin C does not need to be corrected for weight or height to estimate glomerular filtration rate (4 ) .
In young children, capillary blood sampling is often preferred over venipuncture and is used for many biochemical tests. Capillary blood is not suitable for all biochemical tests, however, because it is a mixture of venous and arterial blood and may be contaminated with interstitial or even intracellular fluid. Cystatin C is produced by all nucleated cells in the body (5 ) and enters the interstitium and, from there, the bloodstream. The concentrations of cystatin C have been comparable in most body fluids studied (e.g., blood, tears, milk, saliva, and synovial fluid), and it undergoes only minimal extrarenal metabolism (6 ) .
On the basis of these findings, we concluded that large differences in cystatin C concentrations between blood and interstitial fluid are unlikely, and we hypothesized that cystatin C concentrations are similar in capillary and venous blood samples.
In a pilot study, we measured cystatin C in venous and capillary serum samples. Forty-one adult volunteers, staff members of the Departments of Clinical Chemistry and Pediatrics (median age, 40 years; range, 21-57 years), were asked for informed consent to give blood by both venipuncture and finger capillary puncture. Blood from venipuncture was collected in blood collection tubes (Vacutainer; BD). Capillary puncture was done with Microtainer safety flow lancets, and blood was collected in 0.6-mL tubes (Microtainer; BD). Both devices contained separation gel without anticoagulant. Preanalytical preparation included centrifugation for 10 min at 2000g for venous and 4 min at 21 000g for capillary samples. Serum samples were stored in polyethylene cryovials (Nalgene Labware) at Ϫ20°C until measurement.
Cystatin C was measured by a standard particle-enhanced immunonephelometric assay (N-Latex Cystatin C) on a BN ProSpec nephelometer (Dade Behring). The minimum serum volume needed was 150 L. The assays were performed according to instructions of the manufacturer. To determine the differences and variation between the two sample types, we performed Passing and Bablok regression (7 ) and Bland-Altman analysis (8 ), using MedCalc, Ver. 7.4.20 (MedCalc Software).
Differences between means were tested with the paired t-test. A P value Ͻ0.05 was considered statistically significant. The statistical power to detect a difference in cystatin C concentration of 0.02 mg/L between the two sampling techniques was 90% (9 ) .
For 41 paired capillary (y) and venous (x) samples, the Passing-Bablok regression equation was: y ϭ 1.0357x Ϫ 0.0255 mg/L. The 95% confidence intervals were Ϫ0.1145 to 0.0648 mg/L (not significant) for the intercept and 0.9086 -1.1600 for the slope (not significant). The mean difference between the two methods was 0.006 mg/L (95% confidence interval, Ϫ0.053 to 0.064 mg/L) with no evidence of a concentration-related bias (Fig. 1) . The paired t-test gave a t value of 1.189 (not significant).
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